Edition:
United Kingdom

Opiant Pharmaceuticals Inc (OPNT.OQ)

OPNT.OQ on NASDAQ Stock Exchange Capital Market

22.72USD
8:59pm GMT
Change (% chg)

$-1.74 (-7.11%)
Prev Close
$24.46
Open
$24.37
Day's High
$24.69
Day's Low
$22.60
Volume
4,096
Avg. Vol
12,675
52-wk High
$51.90
52-wk Low
$17.01

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Oct 0.02 -2.772
FY 2017 Jul '17 3.77 -0.166
Apr '17 0.02 -1.554
Jan '17 13.53 4.908
Oct 1.12 -0.301
FY 2016 Jul '16 0.31 -0.546
Apr '16 2.61 0.152
Jan '16 6.86 1.524
Oct 0.12 -6.005
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) 14.34 31.10 32.90
P/E High - Last 5 Yrs. -- 40.92 45.97
P/E Low - Last 5 Yrs. -- 23.79 24.37
Beta -0.31 0.90 0.89
Price to Sales (TTM) 4.86 3.98 5.77
Price to Book (MRQ) 16.95 4.84 5.41
Price to Tangible Book (MRQ) 17.07 5.66 6.98
Price to Cash Flow (TTM) -- 23.02 23.42
% Owned Institutions 1.32 1.25 2.22

Dividends

  Company industry sector
Dividend Yield -- 1.57 1.50
Dividend Yield - 5 Year Avg -- 1.58 1.52
Dividend 5 Year Growth Rate -- 4.33 5.21
Payout Ratio(TTM) 0.00 45.86 43.72

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -99.30 3.67 9.24
Sales (TTM) vs TTM 1 Yr. Ago 43.34 4.72 5.59
Sales - 5 Yr. Growth Rate -- 10.02 10.27
EPS (MRQ) vs Qtr. 1 Yr. Ago -1,121.18 16.64 19.65
EPS (TTM) vs TTM 1 Yr. Ago 148.03 -- --
EPS - 5 Yr. Growth Rate -- 9.82 10.73
Capital Spending - 5 Yr. Growth Rate -- 15.22 15.19

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.11 2.18
Current Ratio (MRQ) 3.13 2.89 2.97
LT Debt to Equity (MRQ) 0.00 9.91 12.22
Total Debt to Equity (MRQ) 0.00 13.93 16.52
Interest Coverage (TTM) -57.11 36.27 33.13

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 55.11 54.70
Gross Margin - 5 Yr. Avg. -- 52.40 52.42
EBITD Margin (TTM) 39.02 -- --
EBITD - 5 Yr. Avg -411.24 18.51 10.86
Operating Margin (TTM) 38.98 14.36 4.64
Operating Margin - 5 Yr. Avg. -411.30 14.42 6.26
Pre-Tax Margin (TTM) 38.90 14.77 5.44
Pre-Tax Margin - 5 Yr. Avg. -418.72 14.73 6.60
Net Profit Margin (TTM) 38.90 11.05 1.76
Net Profit Margin - 5 Yr. Avg. -418.72 11.07 2.91
Effective Tax Rate (TTM) 0.00 23.16 23.04
Effective Tax Rate - 5 Yr. Avg. -- 23.41 23.96

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 948,737,542 855,667,832
Net Income/Employee (TTM) -- 111,622,076 100,655,557
Receivable Turnover (TTM) -- 5.62 5.78
Inventory Turnover (TTM) -- 2.58 3.35
Asset Turnover (TTM) 2.44 0.95 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) 95.09 11.45 10.98
Return on Assets - 5 Yr. Avg. -1,951.46 12.98 12.37
Return on Investment (TTM) 231.11 14.90 14.43
Return on Investment - 5 Yr. Avg. -- 16.98 16.18
Return on Equity (TTM) 2,031.09 16.41 16.13
Return on Equity - 5 Yr. Avg. -- 18.08 17.47
  1 Year 3 Year 5 Year
Sales % 538.55 -- --
EPS (TTM) % -5.37 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Opiant Pharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 5.34%
# of Holders: 18
Total Shares Held: 110,528
3 Mo. Net Change: 63,682
# New Positions: 10
# Closed Positions: 3
# Increased Positions: 14
# Reduced Positions: 5
# Net Buyers: 9
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.